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Abstract
Global dengue virus spread in tropical and sub-tropical regions has become a major international public health concern. It is
evident that DENV genetic diversity plays a significant role in the immunopathology of the disease and that the
identification of polymorphisms associated with adaptive responses is important for vaccine development. The
investigation of naturally occurring genomic variants may play an important role in the comprehension of different
adaptive strategies used by these mutants to evade the human immune system. In order to elucidate this role we
sequenced the complete polyprotein-coding region of thirty-three DENV-3 isolates to characterize variants circulating under
high endemicity in the city of Sa˜o Jose´ de Rio Preto, Brazil, during the onset of the 2006-07 epidemic. By inferring the
evolutionary history on a local-scale and estimating rates of synonymous (dS) and nonsynonimous (dN) substitutions, we
have documented at least two different introductions of DENV-3 into the city and detected 10 polymorphic codon sites
under significant positive selection (dN/dS . 1) and 8 under significant purifying selection (dN/dS , 1). We found several
polymorphic amino acid coding sites in the envelope (15), NS1 (17), NS2A (11), and NS5 (24) genes, which suggests that
these genes may be experiencing relatively recent adaptive changes. Furthermore, some polymorphisms correlated with
changes in the immunogenicity of several epitopes. Our study highlights the existence of significant and informative DENV
variability at the spatio-temporal scale of an urban outbreak.
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Introduction
Dengue viruses (genus flavivirus, family Flaviviridae) are respon-
sible for dengue fever and severe dengue (previously known as
dengue hemorrhagic fever, DHF and dengue shock syndrome,
DSS), they are some of the most important arthropod-borne viral
diseases worldwide [1–4]. Increasing incidences of transmission in
urban and semi-urban areas in the tropical and sub-tropical
countries have promoted dengue to a major public health issue
with a hefty economic burden [5–10].
Dengue epidemics are largely attributed to three factors: (i)
Increased urbanization, (ii) global dissemination of the major
mosquito vectors, Aedes aegypti and Aedes albopictus, and (iii) the
interaction and evolution of the four DENV serotypes [11].
Inadequate sustained vector control may partially explain unsuc-
cessful disease prevention in developing countries however
variables related to the viruses, the human host and the
environment should also be considered [12]. Vaccine development
is currently underway as a strategy for controlling this worldwide
health threat [13–15]. Due to the complexity of DENV dynamics,
prevailing serotypes and differences in distribution of viruses
within different regions of the globe, serotype and lineage
replacement events may play an important role in the evolution
of DENV viruses and, consequently must be addressed during
vaccine development [16].
Gene genealogy-based DENV evolutionary studies helped
characterize the genetic diversity and distribution of different
serotypes/genotypes in space and time [17–22]. Also, they are
important for exploring the role of selection on particular dengue
proteins [23–29]. Given that serotype-specific neutralizing anti-
bodies confer limited, if any, protection from subsequent infection
by the other three serotypes, the appropriate choice of nucleotide
residues in the variable genomic regions is critical for the design of
effective tetravalent vaccines [30,31].
Brazil is the South American country with the highest economic
impact of dengue and also accounts for the majority of reported
cases in the continent as evidenced by a 27 year-long study [8,32].
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The highest dengue incidence was among young adults from 2000
to 2007. However, in 2006 the highest incidence rate of severe
dengue increased dramatically among children and remained high
during severe epidemics in 2007 and 2008 in the state of Rio de
Janeiro [32–34]. These circumstances highlight the urgent need
for continued studies on dengue molecular epidemiology in order
to help determine appropriate policies and effective public health
campaigns.
The municipality of Sa˜o Jose´ de Rio Preto (SJRP), one of the
645 municipalities within the State of Sa˜o Paulo according to the
Brazilian Institute of Geography and Statistics (Instituto Brasileiro de
Geografia e Estatı´stica, IBGE), has a tropical savanna climate
(Ko¨ppen climate classification), with an annual rainfall of
1410 mm and mean annual temperature of 23.6uC, making it a
favorable breeding ground for Aedes mosquitoe vectors. Our
previous study on dengue in SJRP [35] using a 399 bp-long
portion of the NS5 gene, suggested that DENV-3 was introduced
into the city in 2005. Since SJRP is one of the municipalities in Sa˜o
Paulo with the highest number of dengue cases reported yearly
according to the Epidemiological Surveillance Center of the state
(Centro de Vigilaˆncia epidemiolo´gica Alexandre Vranjac, CVE). We chose to
further characterize the isolated DENV-3 strains from SJRP from
2006 to 2007 to gain insights into the viral epidemiology that may
help control disease.
Materials and Methods
Area of study
The city of SJRP is located in the northwestern region of the
state of Sa˜o Paulo, Brazil (20u499110 S and 49u229460 W), with a
total area of 431 km2 and an estimated population of 415,769
inhabitants in 2012 (Data obtained from the IBGE). The
infestation by Aedes mosquitoes was reported for the first time in
1985 and the first autochthonous cases were reported in 1990,
with the introduction of DENV-1 in 1996 (Chiaravalloti-Neto,
Table 1. GenBank and SJRP sequences used for phylogenetic
inference.
Country Year GenBank Accesion Genotype
French Polynesia (PF) 1989 AY744678 I
French Polynesia (PF) 1994 AY744685 I
Indonesia (ID) 2004 AY858048 I
Indonesia (ID) 1982 DQ401690 II
Thailand (TH) 1973 DQ863638 II
Thailand (TH) 2001 FJ810414 II
Taiwan (TW) 1998 DQ675531 II
Vietnam (VN) 2006 EU660411 II
Brazil/Acre 2004 EF629367 III
Brazil/Acre 2004 EF629366 III
Brazil/Central West 2001 FJ913015 III
Brazil/Northern 2003 FJ850079 III
Brazil/Northern 2004 FJ850083 III
Brazil/Northern 2005 FJ850086 III
Brazil/Northern 2006 FJ850089 III
Brazil/Northern 2007 FJ850092 III
Brazil/Northern 2008 FJ850094 III
Brazil/Rio de Janeiro 2002 EF629369 III
Brazil/RP 2006 GQ868548 III
Brazil/RP 2006 GQ868547 III
Brazil/RP 2006 GQ868546 III
Brazil 2001 FJ898446 III
Brazil 2001 FJ177308 III
Brazil 2003 FJ898447 III
Colombia (CO) 2007 GQ868578 III
Mozambique (MZ) 1985 FJ882575 III
Nicaragua (NI) 1994 FJ882576 III
Puerto Rico (PR) 2006 EU529692 III
Sri Lanka (LK) 1983 GQ199889 III
Sri Lanka (LK) 1997 GQ252674 III
Trinidad & Tobago (TT) 2002 GQ868617 III
Venezuela (VE) 2007 GQ868587 III
Brazil/Rondonia (BR) 2002 EF629370 V
Brazil/SJRP 2006 RP06161 III
Brazil/SJRP 2006 RP06391 III
Brazil/SJRP 2006 RP06411 III
Brazil/SJRP 2006 RP06611 III
Brazil/SJRP 2006 RP06641 III
Brazil/SJRP 2006 RP06781 III
Brazil/SJRP 2006 RP06801 III
Brazil/SJRP 2006 RP06921 III
Brazil/SJRP 2006 RP06951 III
Brazil/SJRP 2006 RP061901 III
Brazil/SJRP 2006 V065491 III
Brazil/SJRP 2006 RP06171 III
Brazil/SJRP 2006 RP06231 III
Brazil/SJRP 2006 RP06561 III
Brazil/SJRP 2006 RP06651 III
Table 1. Cont.
Country Year GenBank Accesion Genotype
Brazil/SJRP 2006 RP06791 III
Brazil/SJRP 2006 V061231 III
Brazil/SJRP 2006 RP06541 III
Brazil/SJRP 2007 RP07071 III
Brazil/SJRP 2007 RP07111 III
Brazil/SJRP 2007 RP07031 III
Brazil/SJRP 2007 RP07141 III
Brazil/SJRP 2007 RP07181 III
Brazil/SJRP 2007 RP07191 III
Brazil/SJRP 2007 RP07251 III
Brazil/SJRP 2007 RP07371 III
Brazil/SJRP 2007 RP07411 III
Brazil/SJRP 2007 RP07531 III
Brazil/SJRP 2007 RP07601 III
Brazil/SJRP 2007 RP07611 III
Brazil/SJRP 2007 RP07661 III
Brazil/SJRP 2007 RP07751 III
Brazil/SJRP 2007 RP07081 III
doi:10.1371/journal.pone.0063496.t001
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Superintendence of Endemic Disease Control, SUCEN: personal
communication). Unpublished reports by the Instituto Adolfo Lutz
(Brazilian Public Health Laboratory) point to the introduction of
DENV-2 in 1998. Dengue viruses have been endemic in the
municipality for almost ten years [36].
Sequencing genomes
A total of 33 plasma samples were collected from dengue
patients during the 2006 and 2007 outbreaks as described
elsewhere [35]. Viral RNA was extracted directly from plasma
using the QIAamp Viral RNA mini kit (Qiagen). cDNA was
synthetized in a 20 ml reverse transcription reaction containing:
1 ml of Superscript III Reverse Transcriptase (Invitrogen), 1 ml of
random hexamers (50 ng/ml stock), 1 mL of specific reverse primer
59AGAACCTGTTGATTCAACAGCAC39 (10 mM stock) and
5 ml of template RNA. Viral cDNA were diluted to 800 ml in
DEPC-treated water and 20 ml were used as template for a 96
specific PCR reactions. Each 10 ml PCR reaction contained: 3 ml
of template, 0.03 ml of pfuUltra II polymerase 1 (5 U/ml)
(Stratagene), 100 mM dNTPs (Applied Biosystems) and 4 ml of a
mixture of forward and reverse primers (0.5 mM stock) (Table S1).
Primers were synthesized with M13 sequence tags (forward
primers with 59GTAAAACGACGGCCAGT39 and reverse
primers with 59CAGGAAACAGCTATGACC39) so that PCR
amplicons could be sequenced using universal M13 forward and
reverse primers. Each PCR reaction produced 96 overlapping
amplicons, each 500–900 nucleotides in length, which were
subsequently sequenced bidirectionally using the Big Dye chem-
istry on ABI3730xl DNA sequencers (Applied Biosystems). The 33
obtained genomic sequences were submitted to the Broad Institute
genome project and deposited in GenBank (Table S2 shows all
GenBank accession numbers and name of all samples). (http://
www.broadinstitute.org/annotation/viral/Dengue/).
Phylogenetic Inference
The data set includes the obtained 33 genomic sequences from
SJRP that were aligned together with 33 DENV-3 worldwide
genomic sequences deposited in GenBank (Table 1) using the
Muscle 3.8.31 program [37,38]. Visual inspection of the alignment
and manual editing were done with the Se-Al v2.0 program
(http://tree.bio.ed.ac.uk/software/seal/). A Bayesian maximum
clade credibility tree was inferred from a set of plausible trees
sampled at the stationary phase of four independent Markov
Chain Monte Carlo (MCMC) runs with 40 million generations
each using a general time reversible (GTR) model of nucleotide
substitution [39], a gamma distributed rate variation and a
proportion of invariable sites (GTR + C + I). A relaxed
(uncorrelated lognormal) molecular clock [40] and a Bayesian
Skyline coalescent tree were used as priors [41]. Analyses were
done with Beast v1.6.1 [42]. Convergence of parameters was
assessed using Tracer v1.5 program (http://tree.bio.ed.ac.uk/
software/tracer/) until all parameters estimates showed Effective
Sample Size (ESS) values over 100.
Selection detection analysis
The SJRP dataset was used in a selection analysis to determine
whether amino acid positions were subject to negative or positive
Figure 1. Maximum clade credibility (MMC) tree showing the phylogenetic relationships among SRJP clades (light gray boxes) and
other Brazilian isolates. Posterior probability values are shown for main nodes only. Light grey text represents localities (sources) for other
Brazilian isolates.
doi:10.1371/journal.pone.0063496.g001
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selection pressures. Comparisons were made with the dengue
reference strain Philippines H87/57, following Barrero and
Mistchenko [43] general approach. Both genealogy-based, co-
don-site models Single Likelihood Ancestor Counting (SLAC) and the
Random-Effects (REL) available in the HyPhy package (www.
datamonkey.org) were used to estimate the nonsynonymous (dN)
and synonymous (dS) rates of substitution [44–46]. Polymorphisms
were analyzed with the program DNASP v5 [47] and subjected to
the Tajima D statistic test, as proposed by Tajima [48] to evaluate
deviations from the neutral expectation of molecular evolution
[49].
Epitope and immunogenicity prediction
The amino acid sequences coding for the capsid, envelope,
NS1, NS2a and NS5 proteins were aligned (http://multalin.
toulouse.inra.fr/multalin/multalin.html) and a consensus se-
quence of each protein was submitted to B (http://www.cbs.dtu.
dk/services/BepiPred/) and T (http://www.cbs.dtu.dk/services/
NetCTL/) epitope prediction algorithms. The Allele Frequency
Net Database (http://www.allelefrequencies.net/) was used to
select the HLA classes most predominant in the Southeast of Brazil
and used to set up the NetCTL server. The mean value of the
epitope propensity scores for each sequence was then classified and
plotted according to its potential immunogenicity.
Results and Discussion
Complete genome analyzes define distinct DENV3
lineages circulating in SJRP
The availability of high throughput, parallel DNA sequencing
allows for comprehensive information on population genetics at
the complete viral genome level. In this study, we determined the
sequence of 3390 codon-sites of the complete polyprotein from 33
DENV-3 strains isolated during the 2006 and 2007 outbreaks.
The inferred phylogenetic relationship among DENV-3 strains
was summarized in a Bayesian maximum credibility tree (MCC)
shown in Figure 1. The majority of Brazilian samples grouped
with genotype III, as did most taxa from Latin America isolated
since 1994 [20,50–52]. Likewise, the Brazilian strain EF629370
grouped within genotype I, as previously described by Schreiber et
al. [53]. DENV-3 isolates, other than genotype III, have been
reported in Colombia [54] and in the Brazilian states of Minas
Gerais and Rondonia, likely imported from Asia [55,56]. The
successive circulation of different genotypes is of public health
concern given that distinct combinations could have different
epidemic potentials and risk burdens [57].
The samples from SJRP all fell within genotype III. The MCC
tree indicates that SJRP sequences group with Brazilian isolates
from different regions in highly supported clades (Figure 1). Clade
A included most of SJRP isolates and is more closely related to an
isolate from Acre in 2004 (EF629367_BR_2004). Clade B includes
four SJRP isolates grouping with (i) a sample from Central West
Brazil (FJ913015_BR_2001) and (ii) the Brazilian sample
Table 2. Non-neutral codons according to the assayed methods (SLAC and REL) at the specified significance levels (p = 0.05 and
Bayes factor = 50, respectively).
Region Codon Residue Scaled dN-dS (SLAC) Bayes Factor (REL) Selection
Endoplasmic reticulum
anchor for the protein C
106 V24M10 265.737 Positive
Glycoprotein E: central
and dimerization domains
355 P34 226.589 Negative
Glycoprotein E: central
and dimerization domains
404 P26L7S1 422.066 Positive
Glycoprotein E: central
and dimerization domains
449 T32I1A1 310.144 Positive
Glycoprotein E:
immunoglobulin-like domain
581 T33L1 349.007 Positive
Nonstructural NS1 865 D34 235.355 Negative
Nonstructural NS1 893 K33L1 738.801 Positive
Nonstructural NS1 935 V34 230.491 Negative
Nonstructural NS2B 1401 D34 235.355 Negative
NS3 serine Protease: Domain S7 1634 Y34 235.355 Negative
NS3 serine Protease:
ATP binding domain
1829 A27V6S1 80226.4 Positive
Nonstructural NS4A:
Cytoplasmic domain
2124 H34 235.355 Negative
Nonstructural NS4A:
Lumenal domain
2191 E29D1A1 553.026 Positive
AdoMet-Mtase 2605 P34 230.491 Negative
NS5: Cytoplasmic domain 2862 V34 230.491 Negative
NS5: Cytoplasmic domain 2864 E20G14 527.608 Positive
NS5: Cytoplasmic domain 2879 K32R2 548.683 Positive
NS5: Catalytic domain 3129 P32L1S1 286.641 Positive
doi:10.1371/journal.pone.0063496.t002
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FJ898446_BR_2001 of unknown exactly provenance. Clade C
includes two SJRP isolates from 2007 that cluster with a sequence
from Rio de Janeiro (EF629369_BR_2002) sampled in 2002.
Moreover, in clades A and B there was no temporal separation,
suggesting that the 2007 isolates apparently originated from
previously circulating 2006 lineages. These results suggest distinct
virus introductions into SJRP with one lineage becoming more
prevalent and experiencing in situ evolution (clade A). Co-
circulation of multiple DENV-1 lineages has been documented
in Asian and other Brazilian cities [58,59].
Succession of DENV-3 genotypes in Brazil
Our data also provides information on the movement of
DENV-3 (genotype III) in South America, because sample
FJ850079_BR_2002 obtained in the northern part of Brazil
grouped with Colombian and Venezuelan sequences suggesting a
plausible transmission route.
DENV-3 (genotype III) was isolated for the first time in Brazil
from an autochthonous case of DF in December 2000 from Nova
Iguac¸u, a city located in Rio de Janeiro (RJ) State, which is the
second largest metropolitan area in the country, in 2001- 02, a
large outbreak of DENV-3 occurred in the neighboring city of Rio
de Janeiro [60,61]. Following its introduction into RJ, the virus
spread to the neighboring State of Sa˜o Paulo (SP), and eventually
to the municipality of SJRP. A previous introduction of DENV-3
took place in Brazil in Rondonia State (Amazon region), but
sample EF629370_BR_2002 position in the MCC tree indicates it
belongs to genotype V with its sister taxa coming from Asia.
Nevertheless, most genotype III isolates from the north of Brazil
grouped with the Caribbean strains (samples from Puerto Rico
and Trinidad and Tobago), which suggests the existence of
preferential routes of spread into Brazil, possibly facilitated by
anthropogenic factors [51,62].
The dynamics of viral change
Sequence comparisons using the reference strain Philippines
H87/57 (accession no. M93130) as an outgroup, revealed a total
of 893 nucleotide changes, of which 132 corresponded to non-
synonymous substitutions. The nucleotide diversity p (that is the
average number of nucleotide differences per site between two
sequences) [63] within SJRP strains was 0.0052 6 0.001.
Nevertheless, this p value was one order of magnitude lower than
that for the complete data set used for phylogenetic inference
(n = 0.038 6 261025), which suggests a genetic bottleneck
following the introduction into a new human population, with
the virus experiencing rapid in situ evolution afterwards. This is a
likely scenario given that we sampled from the first documented
DENV-3 outbreak in a city where the local human population is
expected to be largely susceptible to this serotype. Likewise, the
average value of Tajimas’ D for all genes was 21.823 (p,0.05)
Figure 2. Per-site and per-gene dN/dS plot. The calculated SLAC dN/dS and REC posterior probability for positive selection (dN.dS) are plotted
for each site in the upper and lower part of the polyprotein respectively.
doi:10.1371/journal.pone.0063496.g002
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indicating an excess of low frequency polymorphisms, which
would be the case in viral populations expanding following a
selective sweep.
The Tajima’s D value near 22 also implies the outcome of
negative selection, most likely due to functional constraints
imposed on the viral proteins. In agreement with this hypothesis,
the overall dN/dS value for the entire polyprotein coding region
was 0.068 (estimated 95% CI from 0.057 to 0.080) that implied
purifying (stabilizing) selection. Zanotto et al. [64] have argued that
at a coarse-grain, the most common pressure acting on DENV is
purifying selection with little evidence of recent adaptive evolution
when comparing distantly related sequences in space and time,
which would be expected due to synonymous change saturation at
the serotype level. Moreover, given that arboviruses have adapted
to diverse cell types it is generally considered that most mutations
produced are likely to be deleterious [24]. Accordingly, the per-site
SLAC dN/dS analyses revealed that only eight codons were non-
neutral and negatively-selected (p,0.05) (Table 2). Nevertheless,
the presence of low frequency polymorphisms could account for
adaptive changes, such as the 10 sites under significant positive
selection (Bayes factor .50) that we found with the per-site REL
dN/dS analyses.
Selected sites were located in both structural (S) and nonstruc-
tural (NS) proteins (Figure 2). Among the four non-neutral sites
within the envelope protein, codon 355 coding for A Proline
located in the central and dimerization domains, was under
negative selection suggesting its structural importance. Likewise,
positively-selected codons 404 and 581 in the envelope are near
sites associated with disulfide bonds, suggesting adaptive changes
near structurally important residues. Interestingly, Barrero and
Mistchenko [43] also identified codons 581 and 893 (within the
nonstructural NS1 gene) as positively-selected. King et al. [65]
detected a statistically significant positively-selected site in the NS1
gene of DENV-3 genotype II. They also detected selective
pressure in the C and NS4B genes of genotype I and in the E
and NS3 genes of genotype II. We also found additional positively-
selected codon sites; 106 (Endoplasmatic reticulum anchor for the
protein Capsid), 2191 (Lumenal domain of NS4A) and 3129
(catalytic domain of the RNA-directed RNA polymerase) that fell
within domains that are important for membrane interactions/
rearrangements and virus replication.
Polymorphism analysis of individual genomic regions indicated
that the NS5 and the envelope proteins varied the most with 24
and 22 replacement changes respectively, followed by NS1 (17),
NS2A (11), NS4B (8) and Capsid (8) (Table 3). Changes found in
the glycoprotein M, the AdoMet-MTase region and the NS3
serine protease were mostly conservative, while replacements in
the capsid were less conservative. Twiddy et al. [66] found codon
sites 169 and 380 to be under positive selection in DENV-3, with
the latter being located within the central and dimerization
domains of the glycoprotein, which is involved in cell tropism.
Likewise, Rodpothong and Auewarakul [25] reported one codon
site in the prM gene and twelve residues in the E gene to be under
positive selection. In summary, our findings along with others,
suggest that genes other than the envelope may experience
adaptive changes following introduction into a susceptible
population, which implies a possible role for either host-immunity
interaction or vector adaptations that require further study.
Short-term evolution of DENV-3 genotype III
Studies documenting selectively driven evolution in DENV are
limited and mostly available for serotype 2 [25,27–29,43,66],
further studies to better characterize possible specific adaptive
strategies of each serotype are needed. Therefore we looked at
allele replacement in DENV 3 (genotype III).
The allele replacement process, from a population genetics
standpoint, has an explicit genealogic representation, since
frequency increase of an allele will be manifested by appearing
Table 3. Genetic analysis per genomic region.
Region
Codon
Position Sites
Segregating
sites ETA* Pi** K***
NS
sites
S
Sites TajimaD
Capsid Protein C 13–342 330 26 26 0.009 2.806 8 18 21.952
Polyprotein Propeptide 355–612 258 18 18 0.005 1.166 3 15 22.472
Envelope Glycoprotein M 616–840 225 19 19 0.008 1.829 0 19 22.052
Glycoprotein E: central and
dimerization domains
841–1722 882 88 88 0.010 8.513 15 73 22.257
Glycoprotein E:
immunoglobulin-like domain
1726–2013 288 31 31 0.011 3.234 7 24 22.033
NS1 2323–3387 1065 87 88 0.008 8.011 17 71 22.344
NS2A 3406–4029 624 66 66 0.010 6.054 11 55 22.311
NS2B 4039–4419 381 33 34 0.007 2.765 5 29 22.382
NS3 Serine Protease 4459–4923 465 30 30 0.006 2.749 3 27 22.211
DEXDc domain 4987–5811 825 59 60 0.008 2.717 8 52 22.241
NS4A 6286–6720 435 40 40 0.010 4.146 6 34 22.078
NS4B 6727–7455 729 66 66 0.009 6.496 8 58 22.210
AdoMet-MTase 7633–8133 501 34 34 0.008 3.972 1 33 21.864
RNA-directed RNA polymerase 8218–10158 1941 161 162 0.008 15.130 24 138 22.340
Full coding region 1–10170 10170 888 893 0.008 83.398 132 761 22.373
*Total number of mutations.
**Nucleotide diversity.
***Average number of nucleotide differences.
doi:10.1371/journal.pone.0063496.t003
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Figure 3. Positively-selected codon transformations tracked over a clade credibility (MMC) tree. Light gray boxes represent SJRP clades.
Numbers indicates codon position and one-letter symbols indicate amino-acids. Transformations for each character can be evaluated as follows: N
Unique transformation all over the tree;& character state fixed along that branch; b same transformation occurs in another branch (homoplasy); c
DENV-3 Adaptive Changes during Epidemics
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e63496
deeper as a synapomorphy in a viral genealogy [67]. Therefore, a
synapomorphy indicates a fixed allele in the clade defined by it. To
clarify this, we coded each of the ten positively-selected residues as
a set of terminal unordered character states, represented as a single
capital letter. The most parsimonious reconstruction sets of
changes at each internal state in the phylogeny were calculated
with MacClade v4.07 [68] using the MCC tree rooted with the
reference strain Philippines H87/57. The reconstructed changes
are illustrated in Figure 3. They indicate that positively-selected
codons (404, 449, 581, 2191, 2879 and 3129) mapped to internal
nodes as synapomorphies defining the genotype III. For example,
codon 106 Met to Val, (within Protein C, the most non-
conservative region in our study) characterized the SJRP clade
A and codon 404 Pro to Leu characterized the SJRP clade B.
Codon 893 appeared as an autapomorphy for the reference strain
H87/57 (M93130). The synapomorphic changes differentiating
clades A and B that we observed could reflect some aspects of the
intra-genotypic interactions exposed to the human population
[22].
Mondini et al. [35] described the pattern of spread of two
DENV lineages circulating in SJRP, Brazil, during 2006. Based on
82 NS5 sequences, the phylogenetic analysis indicated that all
samples were of DENV-3 and related to strains circulating in
Martinique during 2000–2001. We have considerably extended
that analysis by further showing that different lineages, closely
relate to different Brazilian isolates, were co-circulating while
experiencing distinct adaptive changes as indicated by their
positively-selected synapomorphies. This finding is of relevance,
since in several other viral systems, positively-selected changes are
adaptive in nature and indicative of adaptive changes imposed by
vectors, animal reservoirs or human hosts (i.e., immune escape and
herd immunity) [69–73].
When we observed that DENV-3 sequences, previously
clustered in clades A, B and C (Figure 3), we conducted in silico
analysis to verify the influence of amino acids substitutions in the
immunogenicity of capsid, envelope, NS1, NS2a and NS5
proteins. We found that amino acid substitutions diminished the
B/T epitope propensity scores mainly in the DENV-3 sequences
clustered in clades B and C (Figure 4). These analyses suggest that
amino acid substitutions in sequences grouped in clade A increases
its immunogenicity. As a consequence, DENV-3 strains grouped
in clade A should expose more antigenic epitopes and more
potentially recognized/accessed by the human immune system.
We expected that the most immunogenic strains would be
negatively selected in a given population. In this particular study
we found exactly the opposite. Thus, one can hypothesize that the
ADE phenomenon, which would be responsible for an increased
pathogenicity and replication in host, can also affect the viral
dynamics in a population level. We wonder whether this increased
immunogenicity of clade A can induce an antibody dependent
enhancement (ADE)-like response in the individual leading to high
titers of the virus, which can facilitate the viral transmission to the
mosquitoes and, consequently, increase this strain basic reproduc-
tive rate. Our findings are of relevance given that ADE may be
manifested by challenges imposed by increasing viral immuno-
genic diversity.
While most studies document the broad geographic expansion
of dengue, urban outbreaks dynamics deserves investigation
because they contribute to a better understanding of the genetic
diversity of strains during local transmission; knowledge that could
be exploited for antiviral and vaccine development. In our
analyses of 33 complete polyprotein-coding regions we revealed
distinct lineages and detected polymorphisms sites that correlated
with changes in the immunogenicity of several epitopes. The study
transformation(s) in the same character occurs along that branch; X same transformation occurs in another branch (homoplasy) and
transformation(s) in the same character occur along that branch.
doi:10.1371/journal.pone.0063496.g003
Figure 4. Rank of immunogenicity of DENV-3 sequences. Thirty-three DENV-3 sequences were submitted to B and T epitope prediction using
bioinformatics servers and further classified according to their immunogenic potential. Sequences previously clustered in B and C clades have
epitopes, in envelope, NS1, NS2a and NS5, putatively less immunogenic when compared to the same epitopes of sequences clustered in clade A,
except for sequence ACY70777.1. Substitutions in the capsid were irrelevant.
doi:10.1371/journal.pone.0063496.g004
DENV-3 Adaptive Changes during Epidemics
PLOS ONE | www.plosone.org 8 May 2013 | Volume 8 | Issue 5 | e63496
provides fine-grain information about the molecular epidemiology
of dengue infection.
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